Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/17/2003CN1131031C Use of 4-phenyl-3,6-dihydro-2H-pyridyl derivatives for NMDA receptor subtype blockers
12/17/2003CN1131030C Sleep regulating composition prepared with melatonin and diazepam
12/17/2003CN1131029C Application of dihydromyricetrin in medicine for preparation of hepatitis
12/17/2003CN1131028C Once-a-day methoprolol oral dosage form
12/17/2003CN1131027C Controlled release formulation for poorly soluble basic drugs
12/17/2003CN1131026C Valaciclovir tablets containing colloidal silicon dioxide
12/17/2003CN1131018C Drug-containing adhesive composite transdermal administration plaster and preparation method thereof
12/16/2003US6664420 For therapy of hypertension, type 2 insulin-resistant diabetes mellitus, ecalmpsia and preeclampsia
12/16/2003US6664406 Fatty acid esters used as antiinflammatory or immunomodulatory agents
12/16/2003US6664398 Derivatives of erythromycin, their preparation process and their use as medicaments
12/16/2003US6664397 Administering to subject effective dose of (+)-mefloquine or pharmaceutically acceptable salt thereof substantially free of (-)-enantiomer; reduced side effects
12/16/2003US6664395 Benzotriazole compoundsn are the potent inhibitors of MAP kinases, preferably p38 kinase. They are useful for treating inflammation, osteoarthritis, rheumatoid arthritis, cancer, reperfusion, ischemia
12/16/2003US6664393 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/16/2003US6664389 Highly resistant granular starch
12/16/2003US6664385 Kidney injury-related molecules
12/16/2003US6664300 Process for producing carotenoid emulsion
12/16/2003US6664297 Methods for inhibition and dissolution of amyloidoses by administration of compositions comprising 2,4-dinitrophenol
12/16/2003US6664292 Topically applying to the affected area in the nail a lower alcohol and a lower carboxylic acid to treat the bacterial or fungal infection
12/16/2003US6664291 Malonamic acids and derivatives thereof as thyroid receptor ligands
12/16/2003US6664290 Oral or vaginal administration of mesoprostol in third stage labor
12/16/2003US6664288 Method and composition for the treatment of cancer
12/16/2003US6664286 Lower and control elevated intraocular pressure
12/16/2003US6664285 Use of cell membrane penetrating indigoid bisindole derivatives
12/16/2003US6664284 Stabilized carvedilol injection solution
12/16/2003US6664283 6-amino-N-cyclohexyl-N,3-dimethylthiazolo(3,2-a)benzimidazole-2 -carboxamide dihydrochloride; mGluR1 antagonist
12/16/2003US6664279 Remedies or preventives for liver diseases containing diaminotrifluoromethylpyridine derivatives
12/16/2003US6664276 Antiulcer agent
12/16/2003US6664275 C10 heterosubstituted acetate taxanes
12/16/2003US6664274 Piperidine derivatives as serotonine reuptake inhibitors
12/16/2003US6664273 Having at least cyanobenzyl and amidobenzyl substituents; obesity, metabolic disorders, eating disorders such as hyperphagia and diabetes
12/16/2003US6664272 Such as 1,5-Bis-(2, 4-difluorophenyl)penta-1,4-diene-3 -one; administering to inhibit tissue factor and vascular endothelial growth factor (VEGF) production in cancerous tissue
12/16/2003US6664270 Method and composition for treatment of irritable bowel disease
12/16/2003US6664269 Isoquinolinone derivatives
12/16/2003US6664268 Crystal modification B of 8-cyano-1-cyclopropyl-7-(1S,6S-2, 8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
12/16/2003US6664266 Axon regeneration with PKC inhibitiors
12/16/2003US6664264 Thioether substituted imidazoquinolines
12/16/2003US6664263 1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity
12/16/2003US6664262 N-methoxymethyl-5,5-diphenylbarbituric acid
12/16/2003US6664258 Spirocyclic dopamine receptor subtype ligands
12/16/2003US6664257 Anti-mycobacterial compounds
12/16/2003US6664256 Interleukin- 1 beta inhibitors
12/16/2003US6664255 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
12/16/2003US6664250 Lactam derivatives as antiarrhythmic agents
12/16/2003US6664249 Bicyclic vasopressin agonists
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003US6664246 > 1 x 10-7 mole per liter of a vitamin D compound in an acceptable lipid; anticancer agents
12/16/2003US6664242 Composition and method comprising CPT-11 and a pyrimidine derivative for the treatment of cancer
12/16/2003US6664241 Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
12/16/2003US6664239 Using combination of agents directed toward various stages of life cycle; alzheimer's disease
12/16/2003US6664237 Oral treatment of companion animals with ectoparasiticidal spinosyns
12/16/2003US6664236 Mixtures of glucosides obtained by solvent extraction from plants, comprising barlerin, acetyl barlerin, shanshizide methyl esters and adjuvants, used for detoxification, immunomodulation and as anxiolytic agents
12/16/2003US6664235 Medicaments comprising sialic acid derivatives as active ingredients
12/16/2003US6664233 Combination therapy including 9-nitro-20(S)-camptothecin and bleomycin
12/16/2003US6664069 Use of GABAB receptor agonists in the screening of compounds which are reflux inhibitors
12/16/2003US6664058 A nucleotide, e.g., 6-(beta-D-2-Deoxyribofuranosyl)-5-hydro-methyl-8H-pyrimido(4,5 -c)(1,2)pyridazin-7-one-5'-triphosphate, incorporated into a polynuceotide or an oligomucleotide; viricides; labels
12/16/2003US6664040 Complexing to polypeptides; antiproliferation agent
12/16/2003US6663901 Itraconazole; sugar core, a coating film of a water soluble polymer, a seal coating
12/16/2003US6663900 Processed in a fluidized bed coating machine where a protective coating of a sugar or polyhydric alcohol, starch
12/16/2003US6663897 Oral itraconazole formulations and methods of making the same
12/16/2003US6663896 Delayed release aspirin for vascular obstruction prophylaxis
12/16/2003US6663895 Uniform crystal structure
12/16/2003US6663891 Erythromyacin antibiotic product, use and formulation thereof
12/16/2003US6663890 For therapy of bacterial infection; time-release agents
12/16/2003US6663889 Ambroxol-containing lozenge
12/16/2003US6663887 Compounds and compositions for delivering active agents
12/16/2003US6663881 Therapeutic inhibitor of vascular smooth muscle cells
12/16/2003US6663876 Methods and compositions for treating ectoparasite infestation
12/16/2003US6663874 Comprising an oxidizing agent, first and second polar compounds of dielectric constant greater than 40, such as dimethyl sulfoxide and dimethyl sulfone; for muscle, tendon, joint or ligament pain
12/16/2003US6663872 Immune response
12/16/2003US6663869 Linkages between polypeptide organic molecules are oxime linkages formed by reaction of a keto, aldehyde or amino-oxy group on the amino acid
12/16/2003US6663859 Compositions for enhancing the immune response
12/16/2003US6663858 Antitumor, gene therapy
12/16/2003US6663857 In vivo gene transfer using implanted retroviral producer cells
12/16/2003US6663856 Gene therapy
12/16/2003US6663849 Antacid chewing gum products coated with high viscosity materials
12/16/2003US6663608 Synchronizing of animal oestrus and intra vaginal devices useful therein
12/16/2003CA2382275C Modafinil having defined particle size
12/16/2003CA2341805C Controlled release formulation of divalproex sodium
12/16/2003CA2275299C Indane or dihydroindole derivatives
12/16/2003CA2267165C Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis
12/16/2003CA2259297C Parenteral paclitaxel in a stable non-toxic formulation
12/16/2003CA2246289C New associations of active principles containing clopidogrel and an antithrombotic agent
12/16/2003CA2195125C Difluorostatone antiviral agents
12/16/2003CA2178272C Antiviral monocyclic polyamines
12/16/2003CA2157114C Process for the preparation of 9-desoxotaxanes
12/16/2003CA2134751C Monoclonal antibodies and their use
12/16/2003CA2124578C A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses
12/16/2003CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
12/16/2003CA2119020C 3-hydroxypyridin-4-one derivatives as chelating agents
12/16/2003CA2113894C A process for the preparation of demethylepypodophyllotoxin
12/16/2003CA2093125C Angiotensin ii antagonists
12/16/2003CA2087085C Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antibacterial activity
12/16/2003CA2074495C Propellant compositions
12/14/2003CA2432231A1 Liquid antacid compositions
12/11/2003WO2003102588A2 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
12/11/2003WO2003102245A1 Antisense modulation of beta-site app-cleaving enzyme 2 expression
12/11/2003WO2003102206A2 Sgk and nedd used as diagnostic and therapeutic targets
12/11/2003WO2003102191A1 Immunogenic sequences
12/11/2003WO2003102189A1 Allergen from mugwort pollen
12/11/2003WO2003102158A2 Methods for increasing bone density
1 ... 5243 5244 5245 5246 5247 5248 5249 5250 5251 5252 5253 5254 5255 5256 5257 5258 5259 5260 5261 5262 5263 ... 7860